PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2013112
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2013112
Internet of Medical Things Market size was valued at US$ 272,651.01 Million in 2025, expanding at a CAGR of 18.01% from 2026 to 2033.
The Internet of Medical Things (IoMT) is an advanced technology ecosystem that connects medical devices, healthcare applications, and systems through the internet to enable seamless data exchange. It can be simply understood as a smart network that allows healthcare providers to monitor, collect, and analyze patient data in real time for better clinical decisions. This technology is widely used in applications such as wearable health devices, remote patient monitoring, telemedicine, smart hospitals, and chronic disease management, where continuous data tracking, accuracy, and timely intervention are essential. Overall, IoMT helps make healthcare faster, better, and more connected through smart data use.
Globally, the Internet of Medical Things market is growing due to the rising use of connected healthcare devices, remote monitoring, and real-time data sharing. Healthcare providers are adopting these technologies to improve patient care and efficiency, while an increasing focus on preventive and personalized treatment is driving further growth. Supportive government policies and evolving regulations are also helping expand the use of IoMT solutions. For instance, a September 2021 NCBI study reported that the COVID-19 pandemic significantly increased the use of remote monitoring for cardiac patients across Europe, with around 71.6% of participating centers adopting such systems. This highlights the strong impact of the pandemic on market growth. As COVID-19 cases go down, the need for related patient monitoring devices is also expected to reduce. The market is likely to continue progressing steadily with the ongoing digital transformation in healthcare systems.
Internet Of Medical Things Market- Market Dynamics
Rising Approval Of Over-The-Counter (OTC) Medical Devices To Propel Market Demand
The rising approval of over-the-counter (OTC) medical devices is a key factor driving market growth, as it improves accessibility to advanced health monitoring solutions without prescriptions. Such devices enable convenient health tracking, supporting early detection and effective disease management, thereby increasing adoption among a wider population. In March 2024, the U.S. Food and Drug Administration approved the first over-the-counter (OTC) continuous glucose monitor (CGM) for market use. The Dexcom Stelo Glucose Biosensor System is an integrated CGM designed for individuals aged 18 and above who do not use insulin, including those managing diabetes with oral medications or individuals aiming to monitor how diet and exercise impact blood sugar levels. The expanding role of accessible medical technologies in promoting proactive health management and market growth.
The Global Internet Of Medical Things Market is segmented on the basis of Type, Component, Connectivity, Application, End User, and Region.
Within the type segment, the hardware category is expected to retain a leading position in the Internet of Medical Things (IoMT) market, driven by the growing use of connected medical devices, wearables, and sensors. These components are vital for capturing and transmitting health data, making them the backbone of IoMT systems. Devices such as smartwatches and continuous glucose monitors support continuous tracking of key health metrics like heart rate and glucose levels. For instance, in 2024, according to the European Commission, over 58% of adults in the European Union used a health or fitness tracking device at least once per week, highlighting the growing adoption of wearable technologies. Digital health startups in Europe focused 63% of their wearable solutions on chronic disease management. National health systems in Germany and the Netherlands use wearable data for diabetes and heart care, boosting the wearable tech market. That shows a clear shift toward connected, data-driven healthcare. Strong demand for hardware and integration of wearable data indicates continued growth and innovation in the IoMT market.
Among the various connectivity types, wireless connectivity is projected to account for a major share in the Internet of Medical Things (IoMT) market, supported by its extensive use across remote patient monitoring, wearable devices, telemedicine, home healthcare, and chronic disease management, where flexibility and smooth data transfer are crucial. Technologies like Wi-Fi, Bluetooth, Zigbee, and cellular networks enable efficient communication between devices and healthcare systems, whereas wireless IoMT solutions provide enhanced mobility, convenience, and real-time monitoring, making them well-suited for evolving healthcare requirements. For instance, in 2023, according to the Organisation for Economic Co-operation and Development (OECD) Country Health Profile for Germany, the country continued to have one of the highest levels of public health spending in the European Union; Germany's health spending is 12.9% of GDP (€5,159 per capita), with preventive care doubling over a decade and 88% of adults over 60 vaccinated by 2022, showing improved healthcare performance. Strong healthcare investment and focus on preventive care are expected to further drive the adoption and growth of wireless IoMT solutions.
Internet Of Medical Things Market- Geographical Insights
Across major geographical markets, North America is a key contributor to the Internet of Medical Things (IoMT) market, driven by advanced healthcare infrastructure, high adoption of digital health technologies, and substantial investments in IoMT innovations. The U.S. and Canada are actively integrating connected devices within healthcare systems to enhance patient care, streamline operations, and reduce costs. For instance, in 2024, according to the National Center for Biotechnology Information (NCBI), the digital healthcare industry has experienced rapid growth, with increasing adoption of wearables, telemedicine, AI-driven medical software, and health data platforms. The report highlights that by 2024, millions of individuals worldwide were using digital health solutions for continuous monitoring and remote care, reflecting a notable rise compared with previous years, demonstrating growing momentum in digital healthcare adoption. Therefore, North America is poised to maintain its leadership in the IoMT market, driven by ongoing innovation and widespread digital health adoption.
Within Asia-Pacific, the Internet of Medical Things (IoMT) market is projected to grow steadily during the forecast period, supported by rising disposable incomes, growing health awareness, and government initiatives to enhance IT infrastructure. Increased investment in healthcare digitalization further drives market expansion. The region's growth is also boosted by higher healthcare spending and ample opportunities for business expansion. For instance, in 2024, according to the Japan Critical and Emerging Technologies report by the U.S. Department of Commerce's International Trade Administration, in Japan, rising government IT initiatives are driving expansion in critical and emerging technologies. Japan's AI market is expected to grow from $6.6 billion in 2024 to $35.2 billion by 2033, while the biotechnology sector, valued at $44.1 billion in 2022, will expand steadily, driving innovation in life sciences and digital health. These trends are boosting Japan's high-tech economy and technological development.
China Internet Of Medical Things Market- Country Insights
China is a key player in the Internet of Medical Things (IoMT) market, driven by its focus on healthcare modernization, technological advancement, and digital infrastructure development. Moreover, China's well-developed hospitals, expanding telemedicine ecosystem, and growing consumer health sector contribute to steady demand for connected medical devices, wearable's, and remote patient monitoring solutions. For instance, by the end of 2024, digital health adoption reached significant milestones globally, with approximately 4.88 billion Smartphone users worldwide enabling widespread use of mobile health apps and telemedicine platforms. In China alone, over 418 million people were using digital healthcare services, representing about 37.7% of the internet using population, and more than 3,340 internet hospitals were operating, delivering over 100 million online consultations. The adoption of digital health solutions is expected to further strengthen China's IoMT market and drive continued growth in connected healthcare technologies.
The Internet of Medical Things (IoMT) market is highly dynamic, with global leaders and regional players competing on technology, reliability, connectivity, and cybersecurity. Products are distributed via direct sales, distributors, online platforms, and partnerships. Key players include Medtronic, GE Healthcare, Siemens Healthineers, Philips, Johnson & Johnson MedTech, and Apple, all investing in R&D to expand connected device portfolios. Companies like Medtronic, GE, and Siemens enhance patient care through remote monitoring, cloud-connected platforms, and real-time health data integration. Innovation and integration remain central to maintaining a competitive edge in the global IoMT market. For instance, in May 2021, Medtronic announced the CE approval for the InPen Smart Insulin Pen for multiple daily injections and the Guardian 4 Sensor that requires no fingersticks for diabetes calibration. The smart pen is integrated with real-time CGM via a smartphone app.
In 2025, Honeywell launched a new IoMT-enabled vital signs monitoring device that integrates with hospital information systems for real-time patient data tracking, aimed at enhancing patient safety and operational efficiency in healthcare settings.
In 2024, Johnson & Johnson Services, Inc. completed the acquisition of V-Wave Ltd., a company developing innovative interatrial shunt technology for heart failure treatment, for approximately $600 million upfront (with additional milestone payments possible), strengthening its MedTech portfolio and expanding capabilities in connected medical innovation and cardiovascular care.